321 related articles for article (PubMed ID: 18929791)
1. Indication for splenectomy in the era of living-donor liver transplantation.
Jeng LB; Lee CC; Chiang HC; Chen TH; Hsu CH; Cheng HT; Lai HC
Transplant Proc; 2008 Oct; 40(8):2531-3. PubMed ID: 18929791
[TBL] [Abstract][Full Text] [Related]
2. Adult ABO-incompatible liver transplantation, using A and B donors.
Skogsberg U; Breimer ME; Friman S; Mjörnstedt L; Mölne J; Olausson M; Rydberg L; Svalander CT; Bäckman L
Xenotransplantation; 2006 Mar; 13(2):154-9. PubMed ID: 16623811
[TBL] [Abstract][Full Text] [Related]
3. The role of plasmapheresis therapy for perioperative management in ABO-incompatible adult living donor liver transplantation.
Ashizawa T; Matsuno N; Yokoyama T; Kihara Y; Kuzuoka K; Taira S; Konno O; Jyojima Y; Akashi I; Nakamura Y; Hama K; Iwamoto H; Iwahori T; Nagao T; Kasahara M; Tanaka K
Transplant Proc; 2006 Dec; 38(10):3629-32. PubMed ID: 17175351
[TBL] [Abstract][Full Text] [Related]
4. Impact of graft size on postoperative thrombocytopenia in living donor liver transplant.
Marubashi S; Dono K; Miyamoto A; Takeda Y; Nagano H; Umeshita K; Monden M
Arch Surg; 2007 Nov; 142(11):1054-8. PubMed ID: 18025333
[TBL] [Abstract][Full Text] [Related]
5. Experiences and problems pre-operative anti-CD20 monoclonal antibody infusion therapy with splenectomy and plasma exchange for ABO-incompatible living-donor liver transplantation.
Usui M; Isaji S; Mizuno S; Sakurai H; Uemoto S
Clin Transplant; 2007; 21(1):24-31. PubMed ID: 17302588
[TBL] [Abstract][Full Text] [Related]
6. Splenectomy for reduction of excessive portal hypertension after adult living-related donor liver transplantation.
Sato Y; Yamamoto S; Oya H; Nakatsuka H; Tsukahara A; Kobayashi T; Watanabe T; Hatakeyama K
Hepatogastroenterology; 2002; 49(48):1652-5. PubMed ID: 12397756
[TBL] [Abstract][Full Text] [Related]
7. Prevent small-for-size syndrome using dual grafts in living donor liver transplantation.
Chen Z; Yan L; Li B; Zeng Y; Wen T; Zhao J; Wang W; Xu M; Yang J
J Surg Res; 2009 Aug; 155(2):261-7. PubMed ID: 19481224
[TBL] [Abstract][Full Text] [Related]
8. Isolated liver transplantation for decompensated end-stage liver disease in children with intestinal failure.
Ventura K; Rekhtman Y; Jan D; Emond J; Lobritto S
Transplant Proc; 2006; 38(6):1699-701. PubMed ID: 16908253
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic strategy and the role of apheresis therapy for ABO incompatible living donor liver transplantation.
Kozaki K; Egawa H; Kasahara M; Oike F; Yoshizawa A; Fukatsu A; Tanaka K
Ther Apher Dial; 2005 Aug; 9(4):285-91. PubMed ID: 16076368
[TBL] [Abstract][Full Text] [Related]
10. Liver transplantation using donors older than 80 years: a single-center experience.
Petridis I; Gruttadauria S; Nadalin S; Viganò J; di Francesco F; Pietrosi G; Fili' D; Montalbano M; D'Antoni A; Volpes R; Arcadipane A; Vizzini G; Gridelli B
Transplant Proc; 2008; 40(6):1976-8. PubMed ID: 18675105
[TBL] [Abstract][Full Text] [Related]
11. Effects and problems of adult ABO-incompatible living donor liver transplantation using protocol of plasma exchange, intra-arterial infusion therapy, and anti-CD20 monoclonal antibody without splenectomy: case reports of initial experiences and results in Korea.
Kim BW; Park YK; Kim YB; Wang HJ; Kim MW
Transplant Proc; 2008 Dec; 40(10):3772-7. PubMed ID: 19100487
[TBL] [Abstract][Full Text] [Related]
12. Liver transplantation for acute hepatic failure.
Wu YM; Ho MC; Hu RH; Ko WJ; Yang PM; Lai MY; Lee PH
Transplant Proc; 2004 Oct; 36(8):2226-7. PubMed ID: 15561199
[TBL] [Abstract][Full Text] [Related]
13. The role of apheresis therapy for ABO incompatible living donor liver transplantation: the Kyoto University experience.
Kozaki K; Egawa H; Ueda M; Oike F; Yoshizawa A; Fukatsu A; Takada Y
Ther Apher Dial; 2006 Oct; 10(5):441-8. PubMed ID: 17096700
[TBL] [Abstract][Full Text] [Related]
14. Adult living-donor liver transplantation with ABO-incompatible grafts.
Testa G; Vidanovic V; Chejfec G; Gangemi A; Iqpal R; Porubsky M; Pham T; Benedetti E
Transplantation; 2008 Mar; 85(5):681-6. PubMed ID: 18337660
[TBL] [Abstract][Full Text] [Related]
15. Rituximab, IVIG, and plasma exchange without graft local infusion treatment: a new protocol in ABO incompatible living donor liver transplantation.
Ikegami T; Taketomi A; Soejima Y; Yoshizumi T; Uchiyama H; Harada N; Iguchi T; Hashimoto N; Maehara Y
Transplantation; 2009 Aug; 88(3):303-7. PubMed ID: 19667930
[TBL] [Abstract][Full Text] [Related]
16. Influence of pretransplantation bacterial and fungal culture positivity on outcome after living donor liver transplantation.
Kim BS; Lee SG; Hwang S; Ahn CS; Kim KH; Moon DB; Ha TY; Song GW; Jung DH
Transplant Proc; 2009; 41(1):250-2. PubMed ID: 19249527
[TBL] [Abstract][Full Text] [Related]
17. B-cell surface marker analysis for improvement of rituximab prophylaxis in ABO-incompatible adult living donor liver transplantation.
Egawa H; Ohmori K; Haga H; Tsuji H; Yurugi K; Miyagawa-Hayashino A; Oike F; Fukuda A; Yoshizawa J; Takada Y; Tanaka K; Maekawa T; Ozawa K; Uemoto S
Liver Transpl; 2007 Apr; 13(4):579-88. PubMed ID: 17394164
[TBL] [Abstract][Full Text] [Related]
18. Role of splenectomy in living-donor liver transplantation for adults.
Cescon M; Sugawara Y; Takayama T; Seyama Y; Sano K; Imamura H; Makuuchi M
Hepatogastroenterology; 2002; 49(45):721-3. PubMed ID: 12063978
[TBL] [Abstract][Full Text] [Related]
19. Long-term results after liver transplantation with "livers that nobody wants" within Eurotransplant: a center's experience.
Sotiropoulos GC; Lang H; Saner FH; Beckebaum S; Wandelt M; Molmenti EP; Nadalin S; Treckmann J; Bockhorn M; Fouzas I; Malagó M; Gerken G; Broelsch CE; Paul A
Transplant Proc; 2008 Nov; 40(9):3196-7. PubMed ID: 19010232
[TBL] [Abstract][Full Text] [Related]
20. Survival after orthotopic liver transplantation: the impact of antibody against hepatitis B core antigen in the donor.
Yu L; Koepsell T; Manhart L; Ioannou G
Liver Transpl; 2009 Oct; 15(10):1343-50. PubMed ID: 19790164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
